プログラムされた in vivo Treg 拡張により,AAV 遺伝子治療に対する免疫反応を抑制する
Lavesh Gwalani1, Mincheol Park1, Alexandra B Ysasi1
1Sanofi, Genomic Medicine Unit, Waltham, MA.
Molecular therapy : the journal of the American Society of Gene Therapy
|February 15, 2026
まとめ
THOR-834は,改変されたインタールイキン-2 (IL-2) で,アデノ関連ウイルス (AAV) 遺伝子治療の有効性を改善するために,調節性T細胞 (Tregs) を拡張します. この新しいアプローチは免疫反応を抑制し,トランスゲン発現の持続性を高めます.
科学分野:
- 免疫学 免疫学とは
- 遺伝子療法の遺伝子治療法
- 薬理学 薬理学とは
背景:
- アデノ関連ウイルス (AAV) ベクターは遺伝子治療に不可欠ですが,免疫反応を誘発し,トランスゲン発現の喪失につながります.
- 細胞毒性Tリンパ球 (CTL) と抗体反応は,AAVベクトルの有効性と耐久性を低下させます.
- 調節性T細胞 (Tregs) は免疫反応を抑制することができるが,インタールイキン-2 (IL-2) のような現在の方法は特異性と長寿性が欠けている.
研究 の 目的:
- 新しいPEGYlated IL-2変異体であるTHOR-834を,Tregsを拡張し,AAV遺伝子療法を強化する能力について評価する.
- 臨床前モデルにおけるTHOR-834の免疫調節効果を評価し,T細胞集団と抗体生成に及ぼす影響を含む.
- 持続的なAAVトランスゲン発現のための非ヒト霊長類におけるTHOR-834の種間有効性を確認する.
主な方法:
- THOR-834は,合成のPEGYlated IL-2で,マウス,ラット,Cynomolgus macaqueのモデルに予防的に投与されました.
- 免疫反応は,Treg膨張,CD8+エフェクター記憶T細胞集団,およびAAVカプシドとトランスゲンに対する抗体の位数を測定することによって評価されました.
- AAV遺伝子転送効率とトランスゲン発現持続性は,in vivoで評価されました.
主要な成果:
- ネズミにTHOR-834を予防的に投与すると,Tregsが拡大し,CD8+T細胞が減少し,抗AAVおよび抗トランスゲン抗体の反応が改善された.
- THOR-834は,AAV免疫性に関するラットモデルでのCD8+T細胞応答を効果的に抑制しました.
- cynomolgus macaquesのTHOR-834の単一投与は,Tregsを拡張し,AAVトランスゲン発現を持続させ,種間有効性を実証しました.
結論:
- THOR-834は強力な免疫調節剤で,Tregsを活用してAAVベクトルの免疫性を克服します.
- この戦略は,有害な免疫反応を抑制することによって,AAV遺伝子療法の持続性と有効性を大幅に高めます.
- THOR-834は,AAVベースの遺伝子治療プログラムにおける結果を改善するための有望な治療アプローチを表しています.
関連する概念動画
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Humoral Immune Responses
84.2K
Overview
84.2K
Cell-mediated Immune Responses
84.4K
Overview
84.4K
Cells of the Adaptive Immune Response
9.1K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.1K
Immune Response Against Viral Pathogens
2.1K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.1K
Cells of the Innate Immune Response
9.5K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
9.5K


